BIO-Europe Spring EBD Group BIO BIO-Europe Spring
Share:
Email this page Share this on LinkedIn Share this on Twitter

BIO-Europe Spring® 2015 Press Releases

News for BIO-Europe Spring® 2015 will be available soon

BIO-Europe Spring 2014 press releases

March 20, 2014BIO-Europe Spring® 2014 partnering event brought over 2,000 life science executives to Turin, Italy last week The eighth annual BIO-Europe Spring® international partnering conference took place last week, March 10–12 in Turin, Italy. The event, held at the Oval Lingotto conference center, welcomed more than 2,000 participants representing over 1,200 companies from 42 countries vying for 2,115 licensing opportunities. More than 10,700 one-to-one meetings took place at the event b...  more ►

March 3, 2014BIO-Europe Spring® 2014 kicks off next week in Turin, ItalyEvent is gathering of life science industry leaders
The eighth annual BIO-Europe Spring® conference kicks off in one week on March 10–12 in Turin, Italy. The event is expected to draw over 2,000 high-level executives from pharma, biotech, venture capital firms, and service companies who will be coming to Turin to engage in one-to-one partnering meetings with innovative biotech startups. Delegates are expected to engage in...  more ►

February 25, 2014"Competition fierce" as big pharma moves to early stage deals The focus for Roche meetings at BIO-Europe Spring® breaks out roughly with a third devoted to ongoing relationships, another third focused on active negotiation and one third opportunistic. "We have to spend more time filtering through that last third, but I can tell you we have found programs over the past year that quickly moved to a high priority status."
more ►

February 12, 2014BIO-Europe Spring® program in Turin will engage executives in provocative topics facing drug development industry Life science executives are quickly filling up the program at the eighth annual BIO-Europe Spring® conference to be held March 10–12, 2014 in Turin, Italy. The international bio-pharma partnering event annually attracts top international executives from established and emerging biotech companies; pharmaceutical companies; private investors including venture capital and priva...  more ►

join the conversation ►

January 29, 2014Spotlight on Turin Business Facts A BUSINESS HUB: According to 2012 data provided by the Register of Enterprises, held by the Torino Chamber of Commerce, the number of businesses based in the Torino Province equals 237,000. LIFE SCIENCES: The Turin Life Science sector comprises medium and large companies operating in the following fields: Medical, Electromedical, and Diagnostic instrumentation; Orthopedic pros...  more ►

join the conversation ►

December 12, 2013Turin, Italy welcomes the 2014 edition of BIO-Europe Spring®Pharmaceutical dealmakers converge upon Italian innovation hub
The eighth annual BIO-Europe Spring® conference will be held March 10–12, 2014 in Turin, Italy at the OVAL Lingotto conference center. The event is recognized by life science insiders as the place for established biotech and early-stage companies to meet and form partnerships with venture capitalists and business development executives from big pharma companies. Investor...  more ►

join the conversation ►


partnering360® Blog

September 23, 2014 BioPharm America™ Day 1: 13 Take Aways This week we’re in Boston for BioPharm America™.   Today, we’re recapping the top insights we gained during the day.  The day focused heavily on looking at the benefit of the patient and how important it is to differentiate your product from others and create a better benefit so... more ►

September 21, 2014 European biotech IPOs are slow but steady 2014 has been a strong year for US biotech IPOs, and the venture community has been taking on more risky upstart endeavors with flexible deal terms. According to a September 18 Financial Times article, the Nasdaq biotech index is on the rise again, up 20 percent since January of this year. IPO... more ►

September 19, 2014 Who can you meet next week at BioPharm America™? Next week, 900 plus Pharmaceutical professionals, Innovators and investors will meet in Boston for the BioPharma America ™ event.  With the power of partneringONE®, these companies will be able to meet and form strategic relationships that will move the industry forward. Here are just a few of... more ►

September 17, 2014 FierceBiotech’s 2014 Fierce 15 winners to be announced live at BioPharm America™ FierceBiotech’s annual list of the Fierce 15 involves a hunt for the biggest ideas in biotech, the most daring characters in biopharma, and entrepreneurs doing things that haven’t been done before. The result is fifteen privately held drug developers or platform biotechs with the potential... more ►

September 16, 2014 Innovation at Sanofi Sanofi looks for innovation in it’s drug portfolio in a variety of places – from the acquisitions they’ve made in their business to partnerships with venture capital, biotech and Pharma.  In a recent article at Insight, Gary J. Nabel, Senior VP, CSO and deputy to the President for... more ►



partnering360:Insight Latest headlines from partnering360:Insight

September 17, 2014 Vertex builds out BD group with sharp focus on in-licensing Both at BioPharm America™ in Boston and BIO-Europe® in Frankfurt, Vertex is on the hunt for research to late-stage development opportunities to further strengthen its pipeline through collaborations, part of a strategic shift meant to complement the ongoing internal research and development programs. more ►

September 9, 2014 Flagship Ventures explores the pharma innovation supply chain The care and feeding of the innovation supply chain is a primary focus for Flagship Ventures. While other venture capital firms are focusing on new financing options, this venture firm takes the more holistic approach of fostering innovation among early, disruptive platform companies—many of which they’ve created from scratch in-house—and forging relationships with larger firms that can take the platforms all the way to commercialization. more ►

September 5, 2014 Sanofi finds innovation in many places With ten therapeutic areas plus animal health, Sanofi’s R&D portfolio is well balanced to build upon the strengths of each of the franchises in its portfolio and to capitalize on innovative ideas and projects outside the company. more ►

August 13, 2014 Gene, stem cell therapies bring new players to partnering The next generation of therapies built upon the science of stem cells and genetics will require new types of partnerships. If there is promise that these technologies can redefine how we understand and treat disease, there is already a certainty that the alliances and partnerships required to bring these therapies to patients are also beyond traditional models for commercialization. more ►

August 1, 2014 J&J: “Innovation delivers growth and growth sustains our innovation” "What we are really trying to accomplish is building more than a financial relationship. We are interested in truly finding a way to get to the outcomes. We want to keep our partners intimately involved in a pursuit of truth, in understanding what this science means in the lives of patients who might benefit the most from it. It is this dialogue we are after." more ►



Arrow Up


 
 
See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2014 EBD GmbH
Privacy Policy
Terms of Use
BIO-Europe Spring EBD Group BIO BIO-Europe Spring